MediciNova granted Notice of Allowance for MN-001 patent by USPTO
MediciNova (MNOV) has received a Notice of Allowance from the USPTO for a pending patent application for MN-001 – Tipelukast – to ...
manilatimes4h
Avricore Health Refocuses Strategy to Unlock Growth Potential
HealthTab™ has proven that it can rapidly scale nationally and elevate patient and practitioner experience with point-of-care ...
The Bakersfield Californian5h
MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New ...
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange ...